الرئيسية › دليل الباحثين › Alexandre Prat

Alexandre Prat

الانتماء : Hôpital Notre-Dame · Centre Hospitalier de l’Université de Montréal · Université de Montréal

• 25منشورات (انتماء كندي)
• 547مجموع المنشورات
• 31476الاستشهادات
• 84مؤشر h

ORCIDOpenAlex

مجالات البحث

• Multiple Sclerosis Research Studies
• Neuroinflammation and Neurodegeneration Mechanisms
• Polyomavirus and related diseases
• Barrier Structure and Function Studies
• Psoriasis: Treatment and Pathogenesis

المنشورات (25)

• Effect of late-onset on multiple sclerosis phenotype and outcome: evidence from a multi-national registry
  2026 · Journal of Neurology · استُشهد به 3 مرة
• Preserving Neurological Function in People at High and Low Risk of Aggressive Multiple Sclerosis: An Observational Cohort Study
  2026 · CNS Drugs · استُشهد به 1 مرة
• Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosis
  2026 · medRxiv
• Comparative effectiveness of ocrelizumab in subgroups of patients with multiple sclerosis: a multi-registry observational cohort study
  2026 · Journal of Neurology Neurosurgery & Psychiatry
• Causal effects of multiple sclerosis therapies in left-truncated registry data
  2026 · Multiple Sclerosis Journal
• Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosis
  2026 · Brain
• Pregnancy-Related Disease Outcomes in Women With Moderate to Severe Multiple Sclerosis Disability
  2025 · JAMA Network Open · استُشهد به 7 مرة
• Explainable time-to-progression predictions in multiple sclerosis
  2025 · Computer Methods and Programs in Biomedicine · استُشهد به 7 مرة
• Managing reactivation of multiple sclerosis during treatment with natalizumab
  2025 · Multiple Sclerosis Journal · استُشهد به 1 مرة
• 247 Clinically silent MRI lesions in RRMS: prognostic impact and an emulated trial of disease modifying therapy escalation
  2025
• Machine-learning-based prediction of disability progression in multiple sclerosis: An observational, international, multi-center study
  2024 · PLOS Digital Health · استُشهد به 23 مرة
• A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic
  2024 · Journal of Neurology · استُشهد به 12 مرة
• The risk of secondary progressive multiple sclerosis is geographically determined but modifiable
  2023 · Brain · استُشهد به 29 مرة
• Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis
  2023 · Multiple Sclerosis Journal · استُشهد به 14 مرة
• Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis
  2023 · European Journal of Neurology · استُشهد به 10 مرة
• Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial
  2023 · Journal of Neurology Neurosurgery & Psychiatry · استُشهد به 9 مرة
• Disability accrual in primary and secondary progressive multiple sclerosis
  2023 · Journal of Neurology Neurosurgery & Psychiatry · استُشهد به 7 مرة
• Comparative effectiveness in multiple sclerosis: A methodological comparison
  2023 · Multiple Sclerosis Journal · استُشهد به 6 مرة
• Confirmed disability progression as a marker of permanent disability in multiple sclerosis
  2022 · European Journal of Neurology · استُشهد به 16 مرة
• Early predictors of disability in paediatric multiple sclerosis: evidence from a multi-national registry
  2022 · Journal of Neurology Neurosurgery & Psychiatry · استُشهد به 5 مرة
• Determinants of therapeutic lag in multiple sclerosis
  2021 · Multiple Sclerosis Journal · استُشهد به 6 مرة
• Early clinical markers of aggressive multiple sclerosis
  2020 · Brain · استُشهد به 66 مرة
• Delay from treatment start to full effect of immunotherapies for multiple sclerosis
  2020 · Brain · استُشهد به 44 مرة
• Disability outcomes of early cerebellar and brainstem symptoms in multiple sclerosis
  2020 · Multiple Sclerosis Journal · استُشهد به 20 مرة
• Risk of secondary progressive multiple sclerosis: A longitudinal study
  2019 · Multiple Sclerosis Journal · استُشهد به 81 مرة

مجلات النشر

• Multiple Sclerosis Journal × 7
• Journal of Neurology Neurosurgery & Psychiatry × 4
• Brain × 4
• Journal of Neurology × 2
• European Journal of Neurology × 2
• CNS Drugs × 1

المنشورات حسب السنة

• 20266
• 20254
• 20242
• 20236
• 20222
• 20211
• 20203
• 20191

التعاون العلمي

المؤسسات الشريكة : Centre intégré de santé et de services sociaux de Chaudière-Appalaches · Jewish General Hospital · Centre Hospitalier Universitaire de Sherbrooke · St. Michael's Hospital · Cegep de Saint Jerome

بلدان المؤلفين المشاركين : سويسرا · أيرلندا · المملكة المتحدة

المؤلفون المشاركون

• Marc Girard
• Pierre Duquette
• Pierre Grammond
• Fraser G. A. Moore
• Emmanuelle Lapointe
• Jiwon Oh
• Julie Prévost
• Stella Hughes
• Catherine Larochelle
• F T Moore
• François Grand’Maison
• Jens Kühle

البيانات البيبليوغرافية مصدرها OpenAlex (قاعدة مفتوحة).